Hangzhou Jinnuo Medical Laboratory Co., Ltd.

Hangzhou Jinnuo Medical Laboratory is a research-oriented medical laboratory in Zhejiang Province specializing in cellular and molecular genetics. It is dedicated to promoting the organic integration of medical genetics, genomics, clinical medicine, laboratory medicine, and bioinformatics, integrating cloud computing, genomic big data, and artificial intelligence technologies to become an innovative molecular diagnostic product developer and clinical molecular diagnostic service provider in the fields of reproductive health, prenatal diagnosis, and pediatric genetic diseases. Hangzhou Jinnuo Medical Laboratory has a standardized laboratory with a floor area of approximately 1,700 m2, has built an eight-zone PCR laboratory specializing in clinical molecular diagnostics, and is equipped with a complete set of internationally advanced molecular diagnostic instruments and equipment, high-performance servers for bioinformatics analysis, a cloud computing platform, a laboratory information management system, biobank software and hardware, a high-quality clinical-grade genetic variation database and analysis software, and has established a complete clinical molecular diagnostic technology platform, quality assurance system, talent team, and R&D innovation mechanism. At present, Hangzhou Jinnuo Medical Laboratory focuses on application fields such as rare diseases/hereditary diseases, birth defects, pharmacogenomics, and pathogenic microorganisms, has developed more than 900 clinical molecular diagnostic testing items and promotes its business nationwide, achieving good social and economic benefits. Since its establishment, the company has always attached great importance to R&D innovation and talent team building. The company's R&D innovation team is led by Dr. Zheng Zhaojing and Dr. Geng Juan, and team members are professionals graduated from famous domestic universities such as Shanghai Jiao Tong University, Zhejiang University, Tongji University, and Jinan University, with specialties covering bioinformatics, clinical laboratory diagnostics, clinical medicine, computer science and technology, medical genetics, biology, and others. Among them, personnel with master's degrees or above account for more than 90% of the total R&D personnel. Quality has always been the lifeline of Hangzhou Jinnuo Medical Laboratory. Since its establishment, Hangzhou Jinnuo Medical Laboratory has continuously carried out quality improvement and has passed the external quality assessment (EQA) activities for molecular diagnostic items organized by the Clinical Laboratory Center of the National Health Commission, covering genetic diseases, tumors, pharmacogenomics, and others, with full marks for five consecutive years. At the same time, it has participated in and passed with full marks the proficiency testing (PT) of the College of American Pathologists (CAP) for high-throughput sequencing, chromosomal microarray analysis, and other items for many consecutive years, providing reliable quality assurance for meeting clinical diagnosis and treatment needs. Appendix: Some honors obtained by Hangzhou Jinnuo Medical Laboratory 2017.6 Hangzhou Jinnuo Medical Laboratory was officially approved to join the Genetic Testing Registry (GTR) established by the National Institutes of Health (NIH) of the United States, becoming a third-party independent medical laboratory in China to join this platform; 2017.7 Hangzhou Jinnuo Medical Laboratory met the recognition conditions for municipal-level high-tech enterprises and was recognized as a 2017 Hangzhou *first batch* municipal-level high-tech enterprise; 2017.7 Hangzhou Jinnuo Medical Laboratory was awarded the title of Zhejiang Province Science and Technology-based Small and Medium-sized Enterprise; 2017.9 Hangzhou Jinnuo Medical Laboratory was recognized as a "Zhejiang Province Science and Technology-based Enterprise"; 2018.6 Hangzhou Jinnuo Medical Laboratory was recognized as a science and technology-based enterprise in Yuhang District, Hangzhou; 2018.6 Hangzhou Jinnuo Medical Laboratory was awarded the title of Science and Technology-based Enterprise R&D Center of Yuhang District, Hangzhou; 2018.6 The POC chip independently developed and designed by Hangzhou Jinnuo Medical Laboratory and conforming to the genetic characteristics of the Chinese population was officially promoted externally; 2018.11 Hangzhou Jinnuo Medical Laboratory was recognized as an enterprise in the Hangzhou Science and Technology-based Startup Enterprise Cultivation Project; 2019.4 Hangzhou Jinnuo Medical Laboratory passed the proficiency testing (PT) of the College of American Pathologists (CAP) for the high-throughput sequencing project (NGS) and chromosomal microarray analysis project (CYCGH); 2019.12 Hangzhou Jinnuo Medical Laboratory was recognized as a national high-tech enterprise.